Vancive Medical Technologies has announced it will offer six advanced wound care materials for private...
A line of transparent post-operative dressings designed to enhance patient care will be jointly introduced by Eloquest Healthcare® and Vancive Medical Technologies™.
Called ReliaText™, the dressings have received 510(k) clearance from the US Food and Drug Administration (FDA). It incorporates BeneHold™ CHG, an innovative adhesive technology from Vancive Medical Technologies that comfortably secures the dressing to the skin, absorbs fluids, and protects the site from external contaminants.
The CHG contained within the adhesive preserves the dressings from microbial growth, making them ideally suited for post-operative sites. Eloquest Healthcare is the exclusive distributor of the dressings in the US and Canada.
President and CEO for Eloquest Healthcare said Tim O’Halla said: "The unique characteristics of the ReliaTect post-operative dressings make them a great complement to our growing portfolio and increases the value we are able to provide to our customers.
"The BeneHold CHG adhesive technology delivers the combination of fluid management and sustained transparency with antimicrobial effect of chlorhexidine gluconate, offering clinicians a simple and innovative solution for post-op site management."
The ReliaTect dressings will be available in small and large sizes designed to be ideal for various post-operative sites.
General manager for Vancive Medical Technologies Kirsten Newquist said: "BeneHold CHG adhesive technology adds value to post-operative dressings.
"The collaboration with Eloquest Healthcare brings together complementary resources, experience and expertise from each company. We look forward to working with Eloquest Healthcare to bring ReliaTect to market."
Eloquest Healthcare and Vancive Medical Technologies will showcase the new Eloquest Healthcare ReliaTect dressings in booth #3019 at the AORN Global Surgical Conference & Expo, which is taking place from 2 April 2 to 4 April in Boston, MA.
About Eloquest Healthcare
Eloquest Healthcare is a wholly owned subsidiary of Ferndale Pharma Group. It is focused specifically on serving hospitals, their healthcare practitioners, and patients.
The company helps deliver safer, more compassionate care by providing intuitive, cost-effective solutions that complement treatment protocols.
Vancive has announced it will be an exhibiting at MD&M West this year. The conference...
This study's aim was to quantify and understand the adhesive performance of acrylic pressure-sensitive skin...
Vancive Medical Technologies has announced it will unveil ten new medical adhesive tapes at Medica...